304694-43-7
Chemical Structure
SB-435495 ditartrate
- CAS No.: 304694-43-7
- Formula:C46H52F4N6O14S
- Molecular Weight:1021.00
IUPAC Name: N-(2-(diethylamino)ethyl)-2-(2-((4-fluorobenzyl)thio)-5-((1-methyl-1H-pyrazol-4-yl)methyl)-4-oxopyrimidin-1(4H)-yl)-N-((4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)acetamide bis((2R,3R)-2,3-dihydroxysuccinate)
InChIKey: BCBWEOPNBBMTKX-WBPXWQEISA-N
SMILES: O=C(N(CCN(CC)CC)CC1=CC=C(C2=CC=C(C(F)(F)F)C=C2)C=C1)CN(C(SCC3=CC=C(F)C=C3)=N4)C=C(CC5=CN(C)N=C5)C4=O.OC([C@H](O)[C@@H](O)C(O)=O)=O.OC([C@H](O)[C@@H](O)C(O)=O)=O
Biological Activity: SB-435495 ditartrate is a potent, selective, reversible, non-covalent and orally active Lp-PLA2 inhibitor with an IC50 of 0.06 nM[1][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
SB-435495 ditartrate | SB-435495 ditartrate is a potent, selective, reversible, non-covalent and orally active Lp-PLA2 inhibitor with an IC50 of 0.06 nM. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Blackie JA, et al. The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in man. Bioorg Med Chem Lett. 2002 Sep 16;12(18):2603-6. [Content Brief]
- [3]. Canning P, et al. Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes. Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):7213-8. [Content Brief]
Keywords
